CRP, as a key acute-phase reactant, has been implicated in endothelial dysfunction and vascular wall instability, whereas hypoalbuminemia and lymphopenia reflect impaired antioxidant capacity, disruption of capillary integrity, and reduced cellular immune competence. The gene discussed is CRP; the disease is lymphopenia.